VIDEO: Amarantus BioScience, Inc. (AMBS)

Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostics and therapeutics for the treatment of Alzheimer's disease, Parkinson's disease, and ophthalmological disorders. The company’s diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer’s disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with relapsing-remitting multiple sclerosis at first clinical presentation.

Its therapeutic products in development comprise Eltoprazine, a small molecule drug that is in Phase II clinical trials for the treatment of Parkinson’s disease Levadopa-Induced Dyskinesia and adult attention deficit hyperactivity disorders; and mesencephalic-astrocyte-derived neurotrophic factor for the treatment of various animal models, including iretinitis pigmentosa, Parkinson’s disease, cardiac ischemia, and stroke.

It is also developing NuroPro, a neurodegenerative disease diagnostic platform with application in Parkinson’s disease; BC-SeraPro, an oncology diagnostic platform with application in breast cancer; and PhenoGuard platform for neurrotrophic factor discovery. Amarantus BioScience Holdings, Inc. has a cooperative research and development agreement with the U.S. Army Institute of Surgical Research and Rutgers University to develop its full thickness skin replacement product. The company was formerly known as Amarantus Bioscience, Inc. and changed its name to Amarantus Bioscience Holdings, Inc. in April 2013. Amarantus Bioscience Holdings, Inc. was founded in 2008 and is based in San Francisco, California.


Small Cap Movers


PNK : DPWW - 11 Jul, 2:13pm
+0.00 (+0.00%) After Hours:
Open Mktcap 24.57M
High 52wk Hight
Low 52wk Low
Vol 0 Avg Vol
Eps P/e
Currency: USD


PNK : BKYI - 12 Jul, 3:48pm
-0.0180 (-7.5472%) After Hours:
Open 0.2000 Mktcap 14.63M
High 0.2399 52wk Hight 0.3100
Low 0.2000 52wk Low 0.1000
Vol 36150 Avg Vol 131438
Eps P/e
Currency: USD

Chanticleer Holdings, Inc.

NCM : HOTR - 12 Jul, 4:00pm
+0.045 (+10.000%) After Hours:
Open 0.480 Mktcap 10.56M
High 0.620 52wk Hight 2.730
Low 0.433 52wk Low 0.410
Vol 855941 Avg Vol 74903
Eps -0.270 P/e
Currency: USD

NanoViricides, Inc. NEW Common

ASE : NNVC - 12 Jul, 4:00pm
-0.05 (-2.87%) After Hours:
Open 1.73 Mktcap 97.97M
High 1.75 52wk Hight 3.44
Low 1.68 52wk Low 0.89
Vol 81632 Avg Vol 146763
Eps -0.20 P/e
Currency: USD